High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study

Association of Cystatin-C with Metabolic Syndrome in Normal Glucose-Tolerant Subjects (CURES-97)

(2010) Jatagopi Surendar et al.   Diabetes Technology & Therapeutics

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multiple biomarkers and their relative contributions to identifying metabolic syndrome

(2009) Jeong Gyu Lee et al.   CLINICA CHIMICA ACTA

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation

(2009) R. K. Simmons et al.   DIABETOLOGIA

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive population

(2009) Luis Vigil et al.   Journal of the American Society of Hypertension

Potential Contribution of Adipose Tissue to Elevated Serum Cystatin C in Human Obesity

(2009) Nadia Naour et al.   Obesity

Is Serum Cystatin-C a Reliable Marker for Metabolic Syndrome?

(2008) Aude Servais et al.   AMERICAN JOURNAL OF MEDICINE

Association of Visceral and Subcutaneous Adiposity with Kidney Function

(2008) J. A. Young et al.   Clinical Journal of the American Society of Nephrology

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

(2007) Åsa Lindholm et al.   FERTILITY AND STERILITY